Showing results (2831-2840 of 9,906) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|June 18, 1999
Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cellsF W Preijers, P B van Hennik, A Schattenberg, et al.
Bone Marrow Transplantation|June 18, 1999
Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves' diseaseG A Berisso, M T van Lint, A Bacigalupo, et al.
Bone Marrow Transplantation|May 25, 1999
The role of thiotepa in allogeneic bone marrow transplantation for genetic diseasesF Rosales, N Peylan-Ramu, G Cividalli, et al.
Bone Marrow Transplantation|May 25, 1999
Long-term outcome of adult acute leukemia patients who are alive and well 2 years after autologous blood or marrow transplantationS Singhal, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|May 25, 1999
Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD)F J Child, R Ratnavel, P Watkins, et al.
Bone Marrow Transplantation|May 25, 1999
Production and culture of HSVtk transduced suicidal lymphocytes induces variable changes in the lymphocyte subset compositionF C Marini, S M Kornblau
Bone Marrow Transplantation|May 25, 1999
Parenteral nutrition following intensive cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for haematological malignanciesJ A Iestra, W E Fibbe, A H Zwinderman, et al.
Bone Marrow Transplantation|May 25, 1999
Analgesic infiltration at the site of bone marrow harvest significantly reduces donor morbidityB Chern, N McCarthy, C Hutchins, et al.
Bone Marrow Transplantation|May 25, 1999
Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell supportO Sezer, P Schmid, M Shweigert, et al.
Bone Marrow Transplantation|June 26, 1999
Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC)I Benet, B F Prosper, I Marugan, et al.
Pageof 991